Search Results - "Willen, Daniela"
-
1
Kinetics of free and ligand-bound atacicept in human serum
Published in Frontiers in immunology (02-12-2022)“…BAFF (B cell activation factor of the TNF family/B lymphocyte stimulator, BLyS) and APRIL (a proliferation-inducing ligand) are targeted by atacicept, a decoy…”
Get full text
Journal Article -
2
A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease
Published in Cornea (01-09-2021)“…NOV03 has a unique dual mode of action to address dry eye disease (DED) associated with meibomian gland dysfunction. SEECASE evaluated the efficacy, safety,…”
Get full text
Journal Article -
3
A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease
Published in Cornea (22-12-2020)Get full text
Journal Article -
4
TRAIL: a multifunctional cytokine
Published in Frontiers in bioscience (01-05-2007)“…The Tumor necrosis factor (TNF)-Related Apoptosis Inducing Ligand, TRAIL, has gained much attention due to its specific anti-tumor potential without toxic side…”
Get full text
Journal Article -
5
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects
Published in European journal of drug metabolism and pharmacokinetics (01-02-2020)“…Background and Objective Atacicept is an inhibitor of the B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), and is being studied in…”
Get full text
Journal Article -
6
No interactions between heparin and atacicept, an antagonist of B cell survival cytokines
Published in British journal of pharmacology (01-10-2019)“…Background and Purpose The TNF family ligands, B cell activating factor of the TNF family (BAFF, also known as B lymphocyte stimulator, BLyS) and a…”
Get full text
Journal Article